Read + Share
Seto T, Ohashi K, Sugawara S, Nishio M, et al. Capmatinib in Japanese patients with MET exon 14 skipping-mutated or
MET-amplified advanced NSCLC: GEOMETRY mono-1 study. Cancer Sci 2021;112:1556-1566.
PMID: 33506571
|
 |
|
Seto T, Ohashi K, Sugawara S, Nishio M, et al. Capmatinib in Japanese patients with MET exon 14 skipping-mutated or
MET-amplified advanced NSCLC: GEOMETRY mono-1 study. Cancer Sci 2021;112:1556-1566.
PMID: 33506571
|
|
|
|